English   español  

Navegación por Autor rp12231

Ir a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
O introducir las primeras letras:  
Mostrando resultados 21 a 40 de 162 < Anterior   Siguiente >
DerechosPreviewFecha Public.TítuloAutor(es)Tipo
openAccessHIV-infected_vaccinated_MVA-B.pdf.jpg7-nov-2019Comparison of safety and vector-specific immune responses in healthy and HIV-infected populations vaccinated with MVA-BCouto, Elvira; Diaz-Brito, Vicenç; Mothe, Beatriz; Guardo, Alberto C.; Fernández, Irene; Ugarte, Ainoa; Etcheverry, Flor; Gómez, Carmen E. CSIC ORCID; Esteban, Mariano CSIC ORCID ; Pich, Judit; Arnaiz, Joan Albert; López Bernaldo de Quirós, Juan Carlos; Brander, Christian; Plana, Montserrat; García, Felipe; Leal, Lorna
openAccessJournal of Virology-2021-García-Arriaza-JVI.02260-20.full.pdf.jpg7-ene-2021COVID-19 vaccine candidates based on modified vaccinia virus Ankara expressing the SARS-CoV-2 spike induce robust T- and B-cell immune responses and full efficacy in miceGarcía-Arriaza, Juan CSIC ORCID ; Garaigorta, Urtzi ; Pérez, Patricia; Lázaro-Frías, Adrián; Zamora, Carmen; Gastaminza, Pablo CSIC ORCID; Fresno, Carlos del; Casasnovas, José María CSIC ORCID ; Sorzano, Carlos Óscar S.; Sancho, David; Esteban, Mariano CSIC ORCID artículo
closedAccessaccesoRestringido.pdf.jpg2012Cryo X-ray nano-tomography of vaccinia virus infected cellsChichón, Javier; Rodríguez, María Josefa; Perdiguero, Beatriz; Esteban, Mariano CSIC ORCID ; Carrascosa, José L. CSIC ORCIDartículo
openAccessSituación actual_Alcami.pdf.jpgjul-2005Current situation in the development of a preventive HIV vaccineAlcamí, José CSIC ORCID; Munné, J. J.; Muñoz-Fernández, María Ángeles CSIC ORCID; Esteban, Mariano CSIC ORCID artículo
openAccessGarcía-Arriaza et al., 2014. MVA-B dN2L. J. Virol..pdf.jpgmar-2014Deletion of the vaccinia virus N2L gene encoding an inhibitor of IRF3 improves the immunogenicity of modified vaccinia virus Ankara expressing HIV-1 antigensGarcía-Arriaza, Juan CSIC ORCID ; Gómez, Carmen E. CSIC ORCID; Sorzano, Carlos Óscar S; Esteban, Mariano CSIC ORCID artículo
openAccessDeletion_Perez_Art2020.pdf.jpg2020Deletion of Vaccinia Virus A40R Gene Improves the Immunogenicity of the HIV-1 Vaccine Candidate MVA-BPérez, Patricia; Marín, María Q.; Lázaro-Frías, Adrián; Sorzano, Carlos Óscar S.; Gómez, Carmen E. CSIC ORCID; Esteban, Mariano CSIC ORCID ; García-Arriaza, Juan CSIC ORCID artículo
openAccessAdvanced Science - 2023 - L zaro‐Gorines - Dendritic Cell‐Mediated Cross‐Priming by a Bispecific Neutralizing Antibody.pdf.jpg20-oct-2023Dendritic Cell-Mediated Cross-Priming by a Bispecific Neutralizing Antibody Boosts Cytotoxic T Cell Responses and Protects Mice against SARS-CoV-2Lázaro-Gorines, Rodrigo; Pérez, Patricia; Heras-Murillo, Ignacio; Adán-Barrientos, Irene; Albericio, Guillermo; Astorgano, David; Flores, Sara; Luczkowiak, Joanna; Labiod, Nuria; Harwood, Seandean Lykke; Segura-Tudela, Alejandro; Rubio-Pérez, Laura CSIC; Nugraha, Yudhi; Shang, Xiaoran; Li, Yuxing; Alfonso, Carlos CSIC ORCID ; Adipietro, Kaylin A.; Abeyawardhane, Dinendra L.; Navarro, Rocío; Compte, Marta; Yu, Wenbo; MacKerell Jr., Alexander D.; Sanz, Laura CSIC ORCID; Weber, David J.; Blanco, Francisco J. CSIC ; Esteban, Mariano CSIC ORCID ; Pozharski, Edwin; Godoy-Ruiz, Raquel; Muñoz, Inés G.; Delgado, Rafael; Sancho, David; García-Arriaza, Juan CSIC ORCID ; Álvarez-Vallina, Luisartículo
closedAccess9-ene-2008Differential CD4+ versus CD8+ T-Cell Responses Elicited by Different Poxvirus-Based Human Immunodeficiency Virus Type 1 Vaccine Candidates Provide Comparable Efficacies in PrimatesMooij, Petra; Balla-Jhagjhoorsingh, Sunita S.; Koopman, Gerrit; Beenhakker, Niels; Van Haaften, Patricia; Baak, Ilona; Nieuwenhuis, Ivonne G.; Kondova, Ivanela; Wagner, Ralf; Wolf, Hans; Gómez, Carmen E. CSIC ORCID; Nájera García, José Luis; Jiménez, Victoria; Esteban, Mariano CSIC ORCID ; Heeney, Jonathan L.artículo
openAccessLázaro-Frías et al., 2018. J. Virol..pdf.jpg1-jun-2018Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 ProteinsLázaro-Frías, Adrián; Gómez-Medina, Sergio; Sánchez-Sampedro, Lucas; Ljungberg, Karl; Ustav, Mart; Liljeström, Peter; Muñoz-Fontela, César; Esteban, Mariano CSIC ORCID ; García-Arriaza, Juan CSIC ORCID artículo
openAccessDistinct p21 requirements....pdf.jpg9-ene-2015Distinct p21 requirements for regulating normal and self-reactive T cells through IFN-γ production.Daszkiewicz, Lidia; Vázquez-Mateo, C.; Ballesteros-Tato, A.; Weber, K.; Madrigal-Avilés, A.; Di Pilato, Mauro; Fotedar, A.; Fotedar, R.; Flores, J.M.; Esteban, Mariano CSIC ORCID ; Martínez-A, Carlos CSIC ORCID; Balomenos, Dimitrios CSIC ORCID CVN artículo
openAccessVentoso Ivan Diversity in viral.pdf.jpgfeb-2011Diversity in viral anti-PKR mechanisms: A remarkable case of evolutionary convergenceDomingo-Gil, Elena; Toribio, René CSIC ORCID; Nájera García, José Luis; Esteban, Mariano CSIC ORCID ; Ventoso, Iván CSIC ORCIDartículo
openAccessÖhlund et al., 2018. Scientific Reports.pdf.jpg20-ago-2018DNA-launched RNA replicon vaccines induce potent anti-Ebolavirus immune responses that can be further improved by a recombinant MVA boostÖhlund, Pontus; García-Arriaza, Juan CSIC ORCID ; Zusinaite, Eva; Szurgot, Inga; Männik, Andres; Kraus, Annette; Ustav, Mart; Merits, Andres; Esteban, Mariano CSIC ORCID ; Liljeström, Peter; Ljungberg, Karlartículo
closedAccessaccesoRestringido.pdf.jpg15-sep-2004Efficient CD8+ T cell response to the HIV-env V3 loop epitope from multiple virus isolates by a DNA prime/vaccinia virus boost (rWR and rMVA strains) immunization regime and enhancement by the cytokine IFN-gammaGómez, Carmen E. CSIC ORCID; Abaitua, Fernando; Rodríguez, Dolores; Esteban, Mariano CSIC ORCID artículo
openAccessvaccines-09-00243.pdf.jpg11-mar-2021Emerging SARS-CoV-2 Variants and Impact in Global Vaccination Programs against SARS-CoV-2/COVID-19Gómez, Carmen E. CSIC ORCID; Perdiguero, Beatriz; Esteban, Mariano CSIC ORCID artículo
openAccessfimmu-13-1044025.pdf.jpg24-ene-2023Enhanced cross-recognition of SARS-CoV-2 Omicron variant by peptide vaccine-induced antibodiesAparicio, Belén; Ruiz, Marta; Casares, Noelia; Silva, Leyre; Egea, Josune; Pérez, Patricia; Albericio, Guillermo; Esteban, Mariano CSIC ORCID ; García-Arriaza, Juan CSIC ORCID ; Lasarte, Juan José; Sarobe, Pabloartículo
openAccess46. J. Virol. 2020. ISG15.pdf.jpg22-dic-2020Enhancement of HIV-1 Env-Specific CD8 T Cell Responses Using Interferon-Stimulated Gene 15 as an Immune AdjuvantGómez, Carmen E. CSIC ORCID; Perdiguero, Beatriz; Falqui, Michela; Marín, María Q; Becares, Martina ; Sorzano, Carlos Óscar S; García-Arriaza, Juan CSIC ORCID ; Esteban, Mariano CSIC ORCID ; Guerra, Susanaartículo
openAccessvaccines-09-00959-v2.pdf.jpg27-ago-2021Enhancement of the HIV-1-Specific Immune Response Induced by an mRNA Vaccine through Boosting with a Poxvirus MVA Vector Expressing the Same AntigenGómez, Carmen E. CSIC ORCID; Perdiguero, Beatriz; Usero, Lorena; Marcos-Villar, Laura CSIC ORCID ; Miralles, Laia; Leal, Lorna; Sorzano, Carlos Óscar S.; Sánchez-Corzo, Cristina; Plana, Montserrat; García, Felipe; Esteban, Mariano CSIC ORCID artículo
openAccessaccesoRestringido.pdf.jpg30-mar-2020Estamos preparando la vacuna con un virus de la familia de la viruelaEsteban, Mariano CSIC ORCID ; Romar Gacía, Raúlentrevista
openAccessFull Activation of RNaseL.pdf.jpg1999Full activation of RNaseL in animal cells requires binding of 2-5A within ankyrin repeats 6 to 9 of this interferon-inducible enzymeDíaz-Guerra, Margarita CSIC ORCID; Rivas, Carmen; Esteban, Mariano CSIC ORCID artículo
openAccesss41541-022-00440-w.pdf.jpg9-feb-2022Full efficacy and long-term immunogenicity induced by the SARS-CoV-2 vaccine candidate MVA-CoV2-S in miceLázaro-Frías, Adrián; Pérez, Patricia; Zamora, Carmen; Sánchez-Cordón, P. J.; Guzmán, María; Luczkowiak, Joanna; Delgado, Rafael; Casasnovas, José María CSIC ORCID ; Esteban, Mariano CSIC ORCID ; García-Arriaza, Juan CSIC ORCID artículo